Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential role of the microbiota in prostate cancer pathogenesis and treatment
Nicolò Pernigoni, Christina Guo, Lewis Gallagher, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 12, pp. 706-718
Closed Access | Times Cited: 20

Showing 20 citing articles:

Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Yuhua Zhou, Jing Lv, Shengkai Jin, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Revealing the Urinary Microbiota in Prostate Cancer: A Comprehensive Review Unveiling Insights into Pathogenesis and Clinical Application
Fakhri Alajeeli, Abdullah Salim Al-Karawi, Fadhil M. Abid, et al.
Al-Salam Journal for Medical Science (2024) Vol. 3, Iss. 1, pp. 45-54
Open Access | Times Cited: 10
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
S. Evans, Yash Jani, Caroline S. Jansen, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 6
The Role of the Microbiome in Cancer Therapies
Julia Chalif, Naomi E. S. Goldstein, Yogita Mehra, et al.
Hematology/Oncology Clinics of North America (2025)
Closed Access
Assessing the role of the microbiome in the pathogenesis of prostate cancer and its relationship with patient clinical characteristics
M. Hussain, Rajendra B. Nerli, Suneel Dodamani
DELETED (2025)
Closed Access
Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis
Haotian Huang, Yang Liu, Wen Zhi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities
Sung Jin Kim, Myungchan Park, Ahnryul Choi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 112-112
Open Access | Times Cited: 4
The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications
Jiaren Li, Youyou Li, Liang Zhou, et al.
Microbiological Research (2024) Vol. 281, pp. 127596-127596
Closed Access | Times Cited: 2
Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer
Wenjing Xu, Yingqiu Li, Lumei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Gut microbiome: a novel preventive and therapeutic target for prostatic disease
Hongliang Cao, Difei Zhang, Pengyu Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions
Hanan Qasem, Wael M. El‐Sayed
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
COVID-19, Long COVID, and Gastrointestinal Neoplasms: Exploring the Impact of Gut Microbiota and Oncogenic Interactions
Amália Cínthia Meneses do Rêgo, Irami Araújo-Filho
Archives of Cancer Science and Therapy (2024) Vol. 8, Iss. 1, pp. 054-062
Open Access
Assessing the causal relationship between gut microbiota and prostate cancer: A two-sample Mendelian randomization study
Yijie Wang, Zhaohui Long, Yulong Hong, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Open Access
Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis—a systematic review including meta-analysis of all comparative studies
Ingmar Wolff, Markus Büchner, Katharina Hauner, et al.
Prostate Cancer and Prostatic Diseases (2024)
Open Access
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
Dengxiong Li, Ruicheng Wu, Qingxin Yu, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 6, pp. 596-615
Open Access
The Relationship between Gut Microbiota and Prostate Health
Shang Weon Pak, Yu Seob Shin, Hyun Jun Park
The World Journal of Men s Health (2024) Vol. 42, Iss. 4, pp. 663-663
Open Access
Carbohydrate quality vs quantity on cancer Risk: Perspective of microbiome mechanisms
Lu Liu, Ting Sun, Hongdie Liu, et al.
Journal of Functional Foods (2024) Vol. 118, pp. 106246-106246
Open Access
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case–Control Analysis Within the EPIC Study
Enrique Almanza‐Aguilera, Miriam Martínez‐Huélamo, Yamilé López‐Hernández, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4116-4116
Open Access
Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study
Efthymios Ladoukakis, R.T.D. Oliver, Mark Wilks, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 70-70
Open Access
Poly (ADP-ribose) Polymerase Inhibitors in Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
Chao Zheng, Zefeng Wang, Le Li, et al.
Medicina (2023) Vol. 59, Iss. 12, pp. 2198-2198
Open Access | Times Cited: 1
Page 1

Scroll to top